EDX Medical Group

EDX Medical Group Current Liabilities

The Current Liabilities of EDX Medical Group (EDX.AQ) as of Nov 2, 2026 is 939,600.00 GBP. In the previous year, Current Liabilities was 1.95 M GBP — a change of -51.91% (lower).

Current Liabilities

939,600.00GBP

YoY

-51.91%

Last updated:

Current Liabilities of EDX Medical Group is 2025 939,600.00 GBP. Current Liabilities of EDX Medical Group was 2024 1.95 M GBP. It decreases by -51.91% lower compared to the previous year.

The EDX Medical Group Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2021
11,200.00 GBP
Jan 1, 2022
53,000.00 GBP
Jan 1, 2023
2.37 M GBP
Jan 1, 2024
1.95 M GBP
Jan 1, 2025
939,600.00 GBP
The EDX Medical Group Current Liabilities history
YEARCurrent LiabilitiesYoY
939,600.00GBP-51.91%
1.95 MGBP-17.71%
2.37 MGBP+4,380.00%
53,000.00GBP+373.21%
11,200.00GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EDX Medical Group Stock analysis

What does EDX Medical Group do? EDX Medical Group Plc generates revenue through the sale of digitally enabled diagnostic products and services to individuals and organizations. The company offers point-of-care, home, and workplace testing tools that allow personalized diagnosis according to international standards. Its disease surveillance solutions are sold to cross-border agencies and governments for identifying new disease variants with high transmission risks. The firm also partners with researchers and clinicians to commercialize their discoveries into marketable products. The primary buyers of EDX Medical Group's diagnostic tools include healthcare professionals, individuals seeking personal health monitoring, and government agencies responsible for public health surveillance. Cross-border agencies utilize the disease surveillance solutions to track rapidly spreading variants. Researchers and clinicians form strategic partnerships to develop and launch new diagnostic products through the company's platform. EDX Medical Group's product portfolio consists of diagnostic tests for point-of-care, home, and workplace use, alongside disease surveillance systems. The company's services focus on enabling personalized medical diagnosis and early detection of disease variants. Revenue streams are derived from direct sales of diagnostic tools, government contracts for surveillance systems, and partnership agreements with research institutions. EDX Medical Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EDX Medical Group stock

Current Liabilities of EDX Medical Group is 939,600.00 GBP in 2025.

Current Liabilities of EDX Medical Group changed from 1.95 M GBP to 939,600.00 GBP, representing a -51.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities EDX Medical Group since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's EDX Medical Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — EDX Medical Group

All Key Metrics — EDX Medical Group